The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind.
On 16 June 2017, 107,330,210 Idorsia shares were listed on SIX. Furthermore, shares issued through the conversionof the first tranche of the convertible loan provided by Cilag Holding AG, an indirect subsidiary of Johnson & Johnson (CHF 135.4 million converting into 11,793,220 Idorsia shares (“Authorized Shares”) were listed on 20 June 2017 granting Cilag Holding AG an ownership interest of 9.9% in Idorsia’s share capital.
Idorsia Ltd is part of the following indices: SPI, SPIEX, SXSLI, SXI Life Sciences, and SXI Bio+Medtech.
Idorsia is traded under the following symbols: Reuters IDIA.S / Bloomberg IDIA.
Key Share Data
|As of 31 July 2017|
|Shares outstanding||119.1 million|
|Closing share price||18.10 CHF|
|Market capitalization||2'156.1 million CHF|
|52-week high||21.30 CHF|
|52-week low||10 CHF|
|YTD price change||8.10 CHF (81%)|
|Average daily volume||2.9 million shares|
|Free float||69.8 million shares|
We will update this information quarterly.
Following the new listing of Idorsia Ltd shares on the SIX Swiss Stock Exchange, no shareholders are registered. We will update this information on a regular basis as shareholders begin the registration process.
Martine and Jean-Paul Clozel
Johnson & Johnson
Biotechnology Value Fund
Last update: 31 July 2017. We will update this information quarterly.
How To Buy Stock
Idorsia shares are traded on the SIX Swiss Stock Exchange. Investors wishing to become a shareholder in Idorsia should contact their local bank with the following information:
Reuters / Bloomberg: IDIA.S / IDIA
Exchange: SIX, Switzerland
Swiss security number: 36 346 343
Bank staff will then be able to use this information to execute the transaction.
How To Register Shares
As part of our continued efforts towards good corporate governance we encourage shareholders to exercise their voting rights at the Annual General Meeting (AGM) of Idorsia Ltd.
The registration of shares is not mandatory under Swiss law. Therefore, registered shares are not automatically registered in our Share Register.
Idorsia has mandated areg.ch to administer its Share Register. Investors wishing to register their shares are kindly asked to contact their prime custodian (e.g. your banker or broker) to request a share registration form. After completing the form, your custodian will send it to areg.ch who will then take care of the registration. The custodian will receive a confirmation directly from areg.ch once the registration has taken place.